Immunogenicity of epitope-based DNA vaccines in wild-type Balb/c mice.

The antitumor protection afforded by each plasmid, electroporated 21 and 7 days before a lethal rat HER2-positive TUBO cell challenge, is shown both as tumor-free survival (a) and tumor size (b).